[
  {
    "title": "Moderator",
    "name": "Jeffrey I. Weitz, MD, FRCP(C)",
    "affiliation": "\r\n\r\nProfessor of Medicine<br/>\r\n\r\nMcMaster University <br/>\r\n\r\nHamilton, Ontario, Canada\r\n\r\n",
    "disclosure": "Disclosure: Jeffrey I. Weitz, MD, FRCP(C), has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for: Bayer AG; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Ionis Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Merck --AMPERSAND--amp; Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Portola Pharmaceuticals, Inc.\r\n\r\n<br/><br/>Dr Weitz does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.\r\n\r\n<br/><br/>Dr Weitz does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.\r\n\r\n"
  },
  {
    "title": "Panelist",
    "name": "Alok A. Khorana, MD",
    "affiliation": "\r\n\r\nProfessor of Medicine<br/>\r\n\r\nCleveland Clinic Lerner College of Medicine<br/>\r\n\r\nCleveland, Ohio, United States\r\n\r\n",
    "disclosure": "Disclosure: Alok A. Khorana, MD, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for: AngioDynamics; Bayer AG; Halozyme Therapeutics; Janssen Pharmaceuticals; Pfizer Inc.\r\n\r\n<br/>Received grants for clinical research from: Amgen Inc.\r\n\r\n<br/><br/>Dr Khorana does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.\r\n\r\n<br/><br/>Dr Khorana does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.\r\n\r\nSteering Committee\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Keith A.A. Fox, MBChB, FRCP, FMedSci",
    "affiliation": "\r\n\r\nProfessor of Cardiology, University of Edinburgh, Edinburgh, United Kingdom\r\n\r\n",
    "disclosure": "Disclosure: Keith A.A. Fox, MBChB, FRCP, FMedSci, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc; Sanofi \r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer AG; GlaxoSmithKline; Janssen Pharmaceuticals, Inc. \r\n\r\n<br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi\r\n\r\n\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Craig I. Coleman, PharmD",
    "affiliation": "\r\n\r\nProfessor, University of Connecticut, Storrs, Connecticut \r\n\r\n",
    "disclosure": "Disclosure: Craig I. Coleman, PharmD, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc. \r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Janssen Pharmaceuticals, Inc.\r\n\r\n<br/>Received grants for clinical research from: Bayer AG; Janssen Pharmaceuticals, Inc.; Zoll Medical Corporation\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Gilles Montalescot, MD, PhD",
    "affiliation": "\r\n\r\nProfessor of Cardiology, Institut de Cardiologie, Hôpital la Pitié-Salpêtrière, Paris, France\r\n\r\n",
    "disclosure": "Disclosure: Gilles Montalescot, MD, PhD, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Lilly; Medtronic, Inc.; Menarini; Merck Sharp --AMPERSAND--amp; Dohme GmbH; Pfizer Inc.; sanofi-aventis\r\n\r\n<br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer AG; Bristol-Myers Squibb Company; Medtronic, Inc.; Pfizer Inc.; sanofi-aventis\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Christian T. Ruff, MD, MPH",
    "affiliation": "\r\n\r\nAssistant Professor of Medicine, TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts\r\n\r\n",
    "disclosure": "Disclosure: Christian T. Ruff, MD, MPH, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Portola Pharmaceuticals\r\n\r\n<br/>Received grants for clinical research from: Daiichi Sankyo, Inc.\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Mike Sharma, MD, MSc, FRCPC",
    "affiliation": "\r\n\r\nAssociate Professor, Division of Neurology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada \r\n\r\n",
    "disclosure": "Disclosure: Mike Sharma, MD, MSc, FRCPC, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: AZTherapies, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; \r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company\r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Peter Verhamme, MD, PhD",
    "affiliation": "\r\n\r\nProfessor, University of Leuven, Leuven, Belgium \r\n\r\n",
    "disclosure": "Disclosure: Peter Verhamme, MD, PhD, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Medtronic, Inc.; Pfizer Inc; Portola Pharmaceuticals\r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Pfizer Inc\r\n\r\n<br/>Received grants for clinical research from: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Sanofi \r\n\r\n"
  },
  {
    "title": "Faculty Information and Disclosure Statements",
    "name": "Atul Verma, MD, FRCPC, FHRS",
    "affiliation": "\r\n\r\nAssociate Professor, University of Toronto; Director, Heart Rhythm Program, Southlake Regional Health Center, University of Toronto, Newmarket, Ontario, Canada\r\n\r\n",
    "disclosure": "Disclosure: Atul Verma, MD, FRCPC, FHRS, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: Bayer HealthCare; Biosense Webster, Inc.; Medtronic, Inc.\r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Bayer HealthCare; SERVIER\r\n\r\n<br/>Received grants for clinical research from: Bayer HealthCare; Biosense Webster, Inc.; Medtronic, Inc. \r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Keith A.A. Fox, MBChB, FRCP, FMedSci",
    "affiliation": "\r\n\r\nProfessor of Cardiology, University of Edinburgh, Edinburgh, United Kingdom\r\n\r\n",
    "disclosure": "Disclosure: As listed above.\r\n\r\n\r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Victor Aboyans, MD, PhD",
    "affiliation": "\r\n\r\nProfessor; Head of Department of Cardiology, Dupuytren University Hospital, Limoges, France\r\n\r\n",
    "disclosure": "Disclosure: Victor Aboyans, MD, PhD, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for: Bayer AG\r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.\r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Deepak L. Bhatt, MD, MPH",
    "affiliation": "\r\n\r\nProfessor of Medicine, Harvard Medical School; Executive Director, Interventional Cardiovascular Programs, Brigham and Women's Hospital Heart --AMPERSAND--amp; Vascular Center, Boston, Massachusetts\r\n\r\n",
    "disclosure": "Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Received grants for clinical research from: Amarin Corporation plc; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Chiesi Pharmaceuticals, Inc.; Eisai Inc.; Ethicon, Inc.; Forest Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Ischemix, Inc.; Lilly; Medtronic, Inc.; Pfizer Inc.; Roche; sanofi-aventis; The Medicines Company; \r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Christoph Bode, MD",
    "affiliation": "\r\n\r\nProfessor and Chairman, Cardiology and Angiology, Heart Center Freiburg University, Freiburg, Germany\r\n\r\n",
    "disclosure": "Disclosure: Christoph Bode, MD, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Merck Sharp --AMPERSAND--amp; Dohme GmbH\r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Martin R. Cowie, MD, MSc, FRCP, FRCP (Ed), FESC",
    "affiliation": "\r\n\r\nProfessor of Cardiology, Imperial College London, Royal Brompton Hospital, London, United Kingdom\r\n\r\n",
    "disclosure": "Disclosure: Martin R. Cowie, MD, MSc, FRCP, FRCP (Ed), FESC, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for:  Abbott Laboratories; Bayer AG; Boston Scientific; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; SERVIER\r\n\r\n<br/>Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Bayer AG; Boston Scientific; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Roche; SERVIER\r\n\r\n<br/>Received grants for clinical research from: Bayer AG; Boston Scientific; Medtronic, Inc.; ResMed; Roche\r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "John W. Eikelboom, MBBS, MSc",
    "affiliation": "\r\n\r\nAssociate Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada\r\n\r\n",
    "disclosure": "Disclosure: John W. Eikelboom, MBBS, MSc, has disclosed the following relevant financial relationships:\r\n\r\n<br/>Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc. \r\n\r\n<br/>Received grants for clinical research from: Bayer AG; Daiichi Sankyo, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; sanofi-aventis\r\n\r\n"
  },
  {
    "title": "Vascular Protection Steering Committee ",
    "name": "Manesh R. Patel, MD",
    "affiliation": "\r\n\r\nProfessor of Medicine, Duke University Medical Center, Durham, North Carolina, United States\r\n\r\n",
    "disclosure": "Disclosure: Manesh R. Patel, MD, has disclosed the following relevant financial relationships: \r\n\r\n<br/>Served as an advisor or consultant for:  Bayer AG; Genzyme Corporation; Janssen Pharmaceuticals, Inc.\r\n\r\n<br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Johnson--ENTITY#160;----AMPERSAND--amp;--ENTITY#160;--Johnson Pharmaceutical Research --AMPERSAND--amp; Development, L.L.C.; MAQUET, Inc.; Tryton Medical\r\n\r\n"
  }
]